Skip to main content
. 2022 Jun 21;10(7):986. doi: 10.3390/vaccines10070986
COPD Chronic obstructive pulmonary disease
COVID-19 Coronavirus disease-19
mRNA Messenger ribonucleic acid
T2DM Type 2 diabetes mellitus
SARS-CoV-2 Severe acute respiratory syndrome coronavirus 2
VOC Variants of concern